Nature Genetics, volume 52, issue 9, pages 931-938
RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells
Yicheng Long
1, 2
,
Taeyoung Hwang
1
,
Anne R Gooding
1, 2
,
Karen J. Goodrich
1, 2
,
John L. Rinn
1, 2
,
Thomas R. Cech
1, 2
Publication type: Journal Article
Publication date: 2020-07-06
Journal:
Nature Genetics
Q1
Q1
SJR: 17.300
CiteScore: 43.0
Impact factor: 31.7
ISSN: 10614036, 15461718
Genetics
Abstract
Many chromatin-binding proteins and protein complexes that regulate transcription also bind RNA. One of these, Polycomb repressive complex 2 (PRC2), deposits the H3K27me3 mark of facultative heterochromatin and is required for stem cell differentiation. PRC2 binds RNAs broadly in vivo and in vitro. Yet, the biological importance of this RNA binding remains unsettled. Here, we tackle this question in human induced pluripotent stem cells by using multiple complementary approaches. Perturbation of RNA–PRC2 interaction by RNase A, by a chemical inhibitor of transcription or by an RNA-binding-defective mutant all disrupted PRC2 chromatin occupancy and localization genome wide. The physiological relevance of PRC2–RNA interactions is further underscored by a cardiomyocyte differentiation defect upon genetic disruption. We conclude that PRC2 requires RNA binding for chromatin localization in human pluripotent stem cells and in turn for defining cellular state. Perturbation of RNA–PRC2 interaction in human pluripotent stem cells disrupts PRC2 chromatin occupancy and localization genome wide. PRC2–RNA interactions contribute to cardiomyocyte differentiation.
Found
Found
Top-30
Journals
1
2
3
4
5
6
7
8
9
|
|
Molecular Cell
9 publications, 7.76%
|
|
Proceedings of the National Academy of Sciences of the United States of America
5 publications, 4.31%
|
|
Nature Reviews Molecular Cell Biology
5 publications, 4.31%
|
|
Cell Reports
5 publications, 4.31%
|
|
Nucleic Acids Research
5 publications, 4.31%
|
|
Nature Communications
4 publications, 3.45%
|
|
Nature Genetics
4 publications, 3.45%
|
|
Development (Cambridge)
2 publications, 1.72%
|
|
Biochemical Society Transactions
2 publications, 1.72%
|
|
Cancers
2 publications, 1.72%
|
|
International Journal of Molecular Sciences
2 publications, 1.72%
|
|
Frontiers in Genetics
2 publications, 1.72%
|
|
Frontiers in Cell and Developmental Biology
2 publications, 1.72%
|
|
Oncogene
2 publications, 1.72%
|
|
Seminars in Cancer Biology
2 publications, 1.72%
|
|
Trends in Genetics
2 publications, 1.72%
|
|
Molecular Cancer
1 publication, 0.86%
|
|
Essays in Biochemistry
1 publication, 0.86%
|
|
Open Biology
1 publication, 0.86%
|
|
Viruses
1 publication, 0.86%
|
|
Cells
1 publication, 0.86%
|
|
Frontiers in Cardiovascular Medicine
1 publication, 0.86%
|
|
Frontiers in Oncology
1 publication, 0.86%
|
|
Clinical Epigenetics
1 publication, 0.86%
|
|
Nature Reviews Cancer
1 publication, 0.86%
|
|
Cellular and Molecular Life Sciences
1 publication, 0.86%
|
|
Cell Death and Disease
1 publication, 0.86%
|
|
Epigenetics and Chromatin
1 publication, 0.86%
|
|
Nature
1 publication, 0.86%
|
|
1
2
3
4
5
6
7
8
9
|
Publishers
5
10
15
20
25
30
|
|
Elsevier
29 publications, 25%
|
|
Springer Nature
28 publications, 24.14%
|
|
Cold Spring Harbor Laboratory
14 publications, 12.07%
|
|
MDPI
7 publications, 6.03%
|
|
Frontiers Media S.A.
6 publications, 5.17%
|
|
Proceedings of the National Academy of Sciences (PNAS)
5 publications, 4.31%
|
|
Oxford University Press
5 publications, 4.31%
|
|
Wiley
4 publications, 3.45%
|
|
The Company of Biologists
3 publications, 2.59%
|
|
Portland Press
3 publications, 2.59%
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 1.72%
|
|
The Royal Society
1 publication, 0.86%
|
|
American Physiological Society
1 publication, 0.86%
|
|
American Society of Hematology
1 publication, 0.86%
|
|
European Molecular Biology Organization
1 publication, 0.86%
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.86%
|
|
Pleiades Publishing
1 publication, 0.86%
|
|
The Russian Academy of Sciences
1 publication, 0.86%
|
|
5
10
15
20
25
30
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Long Y. et al. RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells // Nature Genetics. 2020. Vol. 52. No. 9. pp. 931-938.
GOST all authors (up to 50)
Copy
Long Y., Hwang T., Gooding A. R., Goodrich K. J., Rinn J. L., Cech T. R. RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells // Nature Genetics. 2020. Vol. 52. No. 9. pp. 931-938.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/s41588-020-0662-x
UR - https://doi.org/10.1038/s41588-020-0662-x
TI - RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells
T2 - Nature Genetics
AU - Long, Yicheng
AU - Hwang, Taeyoung
AU - Gooding, Anne R
AU - Goodrich, Karen J.
AU - Rinn, John L.
AU - Cech, Thomas R.
PY - 2020
DA - 2020/07/06
PB - Springer Nature
SP - 931-938
IS - 9
VL - 52
SN - 1061-4036
SN - 1546-1718
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Long,
author = {Yicheng Long and Taeyoung Hwang and Anne R Gooding and Karen J. Goodrich and John L. Rinn and Thomas R. Cech},
title = {RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells},
journal = {Nature Genetics},
year = {2020},
volume = {52},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1038/s41588-020-0662-x},
number = {9},
pages = {931--938},
doi = {10.1038/s41588-020-0662-x}
}
Cite this
MLA
Copy
Long, Yicheng, et al. “RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells.” Nature Genetics, vol. 52, no. 9, Jul. 2020, pp. 931-938. https://doi.org/10.1038/s41588-020-0662-x.